Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway

Biochemical and Biophysical Research Communications

Volumn 413, Issue 2, 2011, Pages 264-269

  Jung, Chang Hee ^a   Lee, Woo Je ^a   Hwang, Jenie Yoonoo ^a   Seol, So Mi ^a   Kim, Yun Mi ^a   Lee, Yoo La ^a   Park, Joong Yeol ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Akt; Apoptosis; Endothelial cells; Phosphatidylinositol 3 kinase; Vaspin

Indexed keywords

FATTY ACID; INSULIN; LINOLEIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASPIN; WORTMANNIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL PROTECTION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INSULIN SENSITIVITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

APOPTOSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; HUMANS; INSULIN; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SERPINS; UP-REGULATION;

RATTUS;

EID: 80053107843     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.083     Document Type: Article

References (39)

1. Caterson I.D., Hubbard V., Bray G.A., Grunstein R., Hansen B.C., Hong Y., Labarthe D., Seidell J.C., Smith S.C. Prevention conference VII: obesity a worldwide epidemic related to heart disease and stroke: Group III: Worldwide comorbidities of obesity. Circulation 2004, 110:e476-e483.
2. Choy J.C., Granville D.J., Hunt D.W., McManus B.M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell. Cardiol. 2001, 33:1673-1690.
3. Kelley D.E., Goodpaster B.H. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 2001, 24:933-941.
4. Artwohl M., Roden M., Waldhausl W., Freudenthaler A., Baumgartner-Parzer S.M. Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J. 2004, 18:146-148.
5. Schonfeld P., Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic. Biol. Med. 2008, 45:231-241.
6. Kim F., Tysseling K.A., Rice J., Pham M., Haji L., Gallis B.M., Baas A.S., Paramsothy P., Giachelli C.M., Corson M.A., Raines E.W. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler. Thromb. Vasc. Biol. 2005, 25:989-994.
7. Nystrom F.H., Quon M.J. Insulin signalling: metabolic pathways and mechanisms for specificity. Cell. Signal. 1999, 11:563-574.
8. Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 1999, 274:16349-16354.
9. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
10. Hu L., Sun Y., Hu J. Catalpol inhibits apoptosis in hydrogen peroxide-induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax. Eur. J. Pharmacol. 2010, 628:155-163.
11. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., Hashimoto I., Okada T., Yasuhara A., Nakatsuka A., Shikata K., Hourai S., Futami J., Watanabe E., Matsuki Y., Hiramatsu R., Akagi S., Makino H., Kanwar Y.S. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. USA 2005, 102:10610-10615.
12. Kaneta S., Satoh K., Kano S., Kanda M., Ichihara K. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. Atherosclerosis 2003, 170:237-243.
13. Yu K., Kennedy C.A., O'Neill M.M., Barton R.W., Tatake R.J. Disparate cleavage of poly-(ADP-ribose)-polymerase (PARP) and a synthetic tetrapeptide DEVD, by apoptotic cells. Apoptosis 2001, 6:151-160.
14. Chan S.L., Yu V.C. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin. Exp. Pharmacol. Physiol. 2004, 31:119-128.
15. Azekoshi Y., Yasu T., Watanabe S., Tagawa T., Abe S., Yamakawa K., Uehara Y., Momomura S., Urata H., Ueda S. Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin II production in mononuclear and polymorphonuclear cells. Hypertension 2010, 56:136-142.
16. de Jongh R.T., Serne E.H., Ijzerman R.G., de Vries G., Stehouwer C.D. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance. Hypertens. Microangiopathy, Diabetes 2004, 53:2873-2882.
17. Ko G.T., Chan J.C., Cockram C.S. The association between dyslipidaemia and obesity in Chinese men after adjustment for insulin resistance. Atherosclerosis 1998, 138:153-161.
18. Wozniak S.E., Gee L.L., Wachtel M.S., Frezza E.E. Adipose tissue: the new endocrine organ? A review article. Dig. Dis. Sci. 2009, 54:1847-1856.
19. Yamawaki H. Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses. Biol. Pharm. Bull. 2011, 34:307-310.
20. Ebihara K., Ogawa Y., Masuzaki H., Shintani M., Miyanaga F., Aizawa-Abe M., Hayashi T., Hosoda K., Inoue G., Yoshimasa Y., Gavrilova O., Reitman M.L., Nakao K. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 2001, 50:1440-1448.
21. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
22. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8:731-737.
23. Zeng G., Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by Wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 1996, 98:894-898.
24. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., Quon M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539-1545.
25. Sinor A.D., Lillien L. Akt-1 expression level regulates CNS precursors. J. Neurosci. 2004, 24:8531-8541.
26. Matsui T., Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J. Mol. Cell. Cardiol. 2005, 38:63-71.
27. Shiojima I., Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 2002, 90:1243-1250.
28. Romorini L., Coso O.A., Pecci A. Bcl-XL mediates epidermal growth factor dependent cell survival in HC11 mammary epithelial cells. Biochim. Biophys. Acta 2009, 1793:496-505.
29. Hennig B., Toborek M., McClain C.J. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J. Am. Coll. Nutr. 2001, 20:97-105.
30. Toborek M., Hennig B. The role of linoleic acid in endothelial cell gene expression. Relationship to atherosclerosis. Subcell. Biochem. 1998, 30:415-436.
31. Turpeinen A.M., Basu S., Mutanen M. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prostaglandins Leukot Essent Fatty Acids 1998, 59:229-233.
32. Toborek M., Blanc E.M., Kaiser S., Mattson M.P., Hennig B. Linoleic acid potentiates TNF-mediated oxidative stress. Disruption of calcium homeostasis, and apoptosis of cultured vascular endothelial cells. J. Lipid. Res. 1997, 38:2155-2167.
33. Lee W.J., Lee I.K., Kim H.S., Kim Y.M., Koh E.H., Won J.C., Han S.M., Kim M.S., Jo I., Oh G.T., Park I.S., Youn J.H., Park S.W., Lee K.U., Park J.Y. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2488-2494.
34. Won J.C., Park J.Y., Kim Y.M., Koh E.H., Seol S., Jeon B.H., Han J., Kim J.R., Park T.S., Choi C.S., Lee W.J., Kim M.S., Lee I.K., Youn J.H., Lee K.U. Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha overexpression prevents endothelial apoptosis by increasing ATP/ADP translocase activity. Arterioscler. Thromb. Vasc. Biol. 2010, 30:290-297.
35. Mikhail N. The metabolic syndrome: insulin resistance. Curr. Hypertens. Rep. 2009, 11:156-158.
36. Meshkani R., Adeli K. Hepatic insulin resistance. Metabolic syndrome and cardiovascular disease. Clin. Biochem. 2009, 42:1331-1346.
37. Kadoglou N.P., Gkontopoulos A., Kapelouzou A., Fotiadis G., Theofilogiannakos E.K., Kottas G., Lampropoulos S. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin. Chim. Acta 2011, 412:48-52.
38. Choi S.H., Kwak S.H., Lee Y., Moon M.K., Lim S., Park Y.J., Jang H.C., Kim M.S. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin. Endocrinol. (Oxf.) 2011.
39. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin. Investig. Drugs 2008, 17:327-333.